[yith_wcwl_items_count]

Favorites

Related Posts

Energy

Lose an Hour of Sleep? How Adaptogens Can Help Your Body Adjust

When Daylight Savings Time arrives, many people notice more than just a change on the clock. Losing even one hour of sleep can disrupt your body’s internal rhythm, affecting energy, mood, and stress levels. Adaptogens like those found in Adapten-All may help support the body’s natural ability to adapt during seasonal transitions.

Read More »

Vitamin K2 is an essential lipid soluble vitamin that has three different types: K1, K2 and K3. Albeit Vitamin K is commonly associated with clotting factors or bone health when paired with Vitamin D, it has been reported as potentially useful approach for prevention and clinical treatment of cancer. Vitamin K2 has been found to be milder with minimal side effects while still having function in comparison to other types of Vitamin K.  

Vitamin K2 measured in vitro found to inhibit the proliferation of cancer cells, contributed to cell growth arrest, increasing programmed cell death of cancer cells, inhibiting invasion functionality in cancer cells and synergistic effects in combination with other chemotherapeutics (Xv, 2018).

Liver cancer patients were randomly assigned to receive antineoplastic, sorafenib or sorafenib plus vitamin K2 and found some telling results. Patients were screened for 4 years to find these results in randomized study just published last month:

  • Increased response rate (27.3% vs 4.5%)
  • Extended progression free survival time (4.9 vs 2.9 months)
  • Hazard ratio of 0.044
  • Extended median time of overall survival (26.1 vs 9 months) (Haruna, 2021)

Vitamin K2 appears to be an extremely promising agent with limited toxicity, so consideration should be made in implementing this into clinical therapy.

Haruna, Y., Yakushijin, T. & Kawamoto, S. (2021. Efficacy and safety of sorafenib plus vitamin K treatment for hepatocellular carcinoma: A phase II, randomized study. Cancer Med. 2021 Feb;10(3):914-922. doi: 10.1002/cam4.3674.

Shibayama-Imazu, T., Aiuchi, T. & Nakaya, K. (2008). Vitamin K2-mediated apoptosis in cancer cells: role of mitochondrial transmembrane potential. Vitam Horm. 78:211-26. doi: 10.1016/S0083-6729(07)00010-6.

Xv, F., Chen, J., Duan, L. & Li, S. (2018). Research progress on the anticancer effects of vitamin K2. Oncology Letters. 15: 8926-8934. doi: 10.3892/ol.2018.8502.

If you would like more information, contact Pharmacy Solutions today and speak with one of our pharmacists.

Related Products

Shopping Cart
Pharmacy Solutions - RX Compound

Pharmacy Solutions
1921 W Pioneer Pkwy,
Arlington, TX 76013

Pharmacy Solutions - RX Compound

ATTENTION!

YOUR FORM IS NOT SUBMITTED

To submit your order, click the “PRINT/SAVE” button located under this pop-up. 

Print and Save

You can save the PDF to your computer to fax at a later date or print it now to fax immediately.  

Printing Copy Save

Fax your order form to 817-860-6083 for processing.

Pharmacy Solutions - RX Compound

GLP1s available in all states EXCEPT:

Alabama |
Arkansas
| California
| Michigan
Massachusetts 
| Mississippi
| New Jersey | 
Nevada

ARIZONA | COLORADO | FLORIDA | GEORGIA 
 ILLINOIS | Kansas KENTUCKY | LOUISIANA MISSOURI | NEW YORK OKLAHOMA 
 Pennsylvania | TEXAS

If you have any questions, please call us.

TOLL-FREE: 800-542-5767
PHONE: 817-274-0050